Pharmaceutical

STAT+: Novartis is scolded by U.K. trade group for the ...

For the fourth time this year, Novartis has been reprimanded by a U.K. trade gro...

Free Covid tests will be offered again to all U.S. hous...

The federal government is again offering free Covid tests to Americans, providin...

STAT+: Northeastern among sites chosen by CDC to establ...

The CDC awarded Northeastern $17.5 million over the next five years to develop a...

STAT+: A breakthrough cystic fibrosis drug gave them th...

“It’s been truly miraculous,” said J. Samuel Pope, director of the adult cystic ...

Researchers use AI to measure recovery from treatment-r...

Using brain scans, researchers measured recovery from treatment-resistant depres...

STAT Virtual Event: Putting AI to the Test

STAT sits down with a group of experts who are exploring new ways of evaluating ...

A needle-free anaphylaxis treatment runs into an FDA ro...

The FDA requested more data before advancing a nasal spray for anaphylaxis. The ...

STAT+: Pharmalittle: Lilly sues spas and compounders ov...

Eli Lilly sued several compounding pharmacies, spas, and wellness centers for se...

STAT+: Lilly sues compounders, wellness centers and spa...

The drug company accused four compound pharmacies of violating state laws becaus...

Opinion: Value-based payments are making it harder to s...

The current primary care physician workforce cannot sustain value-based payment ...

Does the risk of getting long Covid increase each time ...

"It's very clear in our data that reinfection contributes additional risk of lon...

STAT+: AI is coming to your dentist’s office. Will it b...

A new wave of AI-powered tools promises to boost dentists’ ability to spot decay...

STAT+: The Apellis eye drug rebound accelerates. This t...

The Apellis eye drug rebound accelerates. This time, it's a competitor falling b...

STAT+: How a cash-prize system that phases out patents ...

"The idea here is you can still get a patent but it wouldn’t be implemented as a...

STAT+: FDA weighs animal data, ethical dilemmas at pane...

An FDA panel, assessing the artificial womb technology, grappled with the limits...

STAT+: PBMs were the target of House hearing, but pharm...

Congress wants PBM reforms to help lower the cost of medicines — but don’t think...